Skip to main content
# Title Department Research Year
461 Combining acetyl salicylic acid and rofecoxib into novel oral tablets normalize platelet function with potential higher tolerability in patients with cardiovascular disorders 2020
462 Latanoprost niosomes as a sustained release ocular delivery system for the
management of glaucoma
Department of Pharmaceutics 2020
463 Synthesis of some new 1,2-disubstituted-1,2,4-triazolobenzimidazoles with antifungal and anti-inflammatory effects. Department of Pharmaceutical Organic Chemistry 2020
464 Enzyme-free and label-free strategy for electrochemical oxaliplatin aptasensing by using rGO/MWCNTs loaded with AuPd nanoparticles as signal probes and electro-catalytic enhancers Department of Pharmaceutical Analytical Chemistry 2020
465 Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19 Department of Pharmaceutics 2020
466 Design and synthesis of some 1,3,5-tri-substituted oxindole derivatives as potential CDK inhibitors Department of Medicinal Chemistry 2020
467 Antimicrobial Pyridazines: Synthesis, Characterization, Cytotoxicity, Substrate Promiscuity, and Molecular Docking Department of Pharmaceutical Organic Chemistry 2020
468 Severe cutaneous adverse drug reactions: Incidence, Clinical Patterns, Causative Drugs and Modalities of Treatment in Assiut University Hospital, Upper Egypt 2020
469 Novel Sponge-Like Mn5O8 Nanoparticles Deposited on Graphite Electrode for Electrochemical Study of Hepatitis C Antiviral Drug, Elbasvir 2020
470 Epigallocatechin-3-Gallate-Loaded Gold
Nanoparticles: Preparation and Evaluation of
Anticancer Efficacy in Ehrlich Tumor-Bearing Mice
Department of Pharmaceutics 2020